Omega Healthcare Investors, Inc. (NYSE:OHI) Given Consensus Rating of "Moderate Buy" by Analysts

Omega Healthcare Investors, Inc. (NYSE:OHI - Get Free Report) has received an average recommendation of "Moderate Buy" from the twelve brokerages that are currently covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $33.58.

OHI has been the topic of several research reports. BNP Paribas upgraded shares of Omega Healthcare Investors from an "underperform" rating to a "neutral" rating and set a $30.00 price objective on the stock in a report on Thursday, February 8th. Wells Fargo & Company upgraded shares of Omega Healthcare Investors from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $31.00 to $35.00 in a report on Monday, February 26th. Bank of America downgraded shares of Omega Healthcare Investors from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $33.00 to $31.00 in a report on Tuesday, January 16th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Omega Healthcare Investors in a report on Tuesday, January 30th. They set a "buy" rating and a $36.00 price objective on the stock. Finally, Mizuho dropped their price objective on shares of Omega Healthcare Investors from $35.00 to $34.00 and set a "buy" rating on the stock in a report on Wednesday, January 3rd.

Hedge Funds Weigh In On Omega Healthcare Investors

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OHI. MeadowBrook Investment Advisors LLC acquired a new position in Omega Healthcare Investors in the fourth quarter valued at about $31,000. Peoples Bank KS acquired a new position in Omega Healthcare Investors in the third quarter valued at about $33,000. NBC Securities Inc. acquired a new position in Omega Healthcare Investors in the third quarter valued at about $34,000. GAMMA Investing LLC acquired a new position in Omega Healthcare Investors in the fourth quarter valued at about $35,000. Finally, Highlander Capital Management LLC raised its stake in shares of Omega Healthcare Investors by 150.0% in the fourth quarter. Highlander Capital Management LLC now owns 1,250 shares of the real estate investment trust's stock worth $38,000 after acquiring an additional 750 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Performance

OHI traded up $0.43 during trading on Tuesday, hitting $30.70. The stock had a trading volume of 1,604,279 shares, compared to its average volume of 1,762,266. The firm has a market cap of $7.53 billion, a PE ratio of 30.91, a P/E/G ratio of 9.96 and a beta of 0.91. Omega Healthcare Investors has a 12 month low of $26.00 and a 12 month high of $34.77. The company has a current ratio of 6.76, a quick ratio of 6.76 and a debt-to-equity ratio of 1.35. The company has a 50 day simple moving average of $31.01 and a 200-day simple moving average of $31.17.

Omega Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Tuesday, April 30th will be given a $0.67 dividend. The ex-dividend date of this dividend is Monday, April 29th. This represents a $2.68 dividend on an annualized basis and a yield of 8.73%. Omega Healthcare Investors's dividend payout ratio (DPR) is presently 270.71%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.